Now we have medications for obesity, but they are not for losing a couple of kilos. An integrative approach of all available measures is needed
Researchers have used artificial intelligence to find out why some people have a better response to GLP-1 agonists
The Princeton researcher has published a book in which she reviews what is known about the science of living longer and healthier lives
The businesswoman presented a special on diets and drugs such as Ozempic, which she previously criticized and now, prudently, embraces: ‘Let’s stop shaming other people for being overweight or how they choose to lose or not lose weight’
Citi estimates that the fight against obesity will generate revenue of $158 billion in 2035. The main risk for the sector is the difficulty in guaranteeing supply
